TY - JOUR
T1 - CXCR4 induction in hematopoietic progenitor cells from Fanca-/-, -c-/-, and -d2-/- mice
AU - Skinner, Amy
AU - O'Neill, S. Lee
AU - Grompe, Markus
AU - Kurre, Peter
N1 - Funding Information:
This study was supported in part by National Institutes of Health grant HL077231 and the Friends of Doernbecher. We wish to thank Yung-Wei Pan for his contributions to these experiments. We acknowledge the assistance of Tammy T. Luoh and Daniel Kwon. We wish to thank Dr. Steve Back for use of his hypoxia chamber and Dr. Daniel Marks for use of his real-time thermocycler. We also thank Paul Lees, M.S. for performing statistical computations. Aspects of this work were presented at the 48th Annual Meeting of the American Society of Hematology, Orlando, FL 2006 and the 19th Annual Scientific Meeting of the Fanconi Anemia Research Fund in Chicago, IL 2007.
PY - 2008/3
Y1 - 2008/3
N2 - Objective: Bone marrow failure is a near-universal occurrence in patients with Fanconi anemia (FA) and is thought to result from exhaustion of the hematopoietic stem cell (HSC) pool. Retrovirus-mediated expression of the deficient protein corrects this phenotype and makes FA a candidate disease for HSC-directed gene therapy. However, inherent repopulation deficits and stem cell attrition during conventional transduction culture prevent therapeutic chimerism. Materials and Methods: We previously reported rapid transduction protocols to limit stem cell losses after ex vivo culture. Here we describe a complementary strategy intended to improve repopulation through upregulation of chemokine receptor (CXCR) 4, a principal factor in hematopoietic homing. Results: Using murine models with transgenic disruption of Fanca, -c, and -d2, we found that c-kit+ and sca-1+ progenitor cells express levels of CXCR4 comparable with those of wild-type littermates. Lineage-depleted progenitor populations rapidly upregulated CXCR4 transcript and protein in response to cytokine stimulation or hypoxia, regardless of genotype. Hypoxia conditioning of lineage-depleted Fancc-/- progenitors also reduced oxidative stress, improved in vitro migration and led to improved chimerism in myeloablated recipients after transplantation. Conclusion: These studies provide evidence that CXCR4 regulation in progenitor cells from transgenic mice representing multiple FA genotypes is intact and that modulation of homing offers a potential strategy to offset the FA HSC repopulation deficiency.
AB - Objective: Bone marrow failure is a near-universal occurrence in patients with Fanconi anemia (FA) and is thought to result from exhaustion of the hematopoietic stem cell (HSC) pool. Retrovirus-mediated expression of the deficient protein corrects this phenotype and makes FA a candidate disease for HSC-directed gene therapy. However, inherent repopulation deficits and stem cell attrition during conventional transduction culture prevent therapeutic chimerism. Materials and Methods: We previously reported rapid transduction protocols to limit stem cell losses after ex vivo culture. Here we describe a complementary strategy intended to improve repopulation through upregulation of chemokine receptor (CXCR) 4, a principal factor in hematopoietic homing. Results: Using murine models with transgenic disruption of Fanca, -c, and -d2, we found that c-kit+ and sca-1+ progenitor cells express levels of CXCR4 comparable with those of wild-type littermates. Lineage-depleted progenitor populations rapidly upregulated CXCR4 transcript and protein in response to cytokine stimulation or hypoxia, regardless of genotype. Hypoxia conditioning of lineage-depleted Fancc-/- progenitors also reduced oxidative stress, improved in vitro migration and led to improved chimerism in myeloablated recipients after transplantation. Conclusion: These studies provide evidence that CXCR4 regulation in progenitor cells from transgenic mice representing multiple FA genotypes is intact and that modulation of homing offers a potential strategy to offset the FA HSC repopulation deficiency.
UR - http://www.scopus.com/inward/record.url?scp=38949138812&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=38949138812&partnerID=8YFLogxK
U2 - 10.1016/j.exphem.2007.11.006
DO - 10.1016/j.exphem.2007.11.006
M3 - Article
C2 - 18279715
AN - SCOPUS:38949138812
SN - 0301-472X
VL - 36
SP - 273
EP - 282
JO - Experimental hematology
JF - Experimental hematology
IS - 3
ER -